Q3 FY2026 · ended Sep 30, 2026 · Revenue $24.20M, +14.2% YoY · Filed Oct 30, 2026
Iradimed Corporation (IRMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $24.2 million and net income of $6.5 million. Free cash flow was $6.9 million.
Revenue
$24.20M
+14.2% vs year-ago quarter
Net income
$6.51M
+16.7% vs year-ago quarter
Operating cash flow
$7.00M
+0.2% vs year-ago quarter
Free cash flow
$6.87M
+17.4% vs year-ago quarter
EPS
$0.51
+18.6% vs year-ago quarter
Dividend per share
None
Shares outstanding
12.79M
+0.5% vs year-ago quarter
Net cash
$50.27M
Q1 FY2025
Operating margin
32.3%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IRMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Orlando, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1325618
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $24.2M | $20.5M | $22.0M | $22.7M | $21.2M |
| Operating income | $8.1M | $6.4M | $7.2M | $7.1M | $6.8M |
| Net income | $6.5M | $5.2M | $5.8M | $6.4M | $5.6M |
| Diluted EPS | $0.51 | $0.41 | $0.45 | $0.50 | $0.43 |
| Operating cash flow | $7.0M | $5.9M | $8.3M | $5.9M | $7.0M |
| Free cash flow | $6.9M | $5.8M | $7.9M | $5.6M | $5.8M |
| Total assets | $121.1M | $115.0M | $114.4M | $108.8M | $114.7M |
| Total liabilities | $14.6M | $13.2M | $15.9M | $14.2M | $16.4M |
| Stockholders' equity | $106.5M | $101.7M | $98.5M | $94.6M | $98.4M |
| Cash and investments | $63.3M | $59.1M | $56.4M | $51.2M | $56.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 18, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
All 777 Iradimed Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.